Galectin Therapeutics (GALT) Goodwill & Intangibles (2010 - 2016)
Galectin Therapeutics' (GALT) quarterly Goodwill & Intangibles came in at $78000.0 in Q4 2016, little changed year-on-year from $78000.0 in Q1 2016, and up 2500.0% quarter-over-quarter from $3000.0 in Q3 2016.
Galectin Therapeutics (GALT) Goodwill & Intangibles (2010 - 2016) Analysis & Trends
Galectin Therapeutics' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $78000.0 for Q4 2016.
- On a quarterly basis, Goodwill & Intangibles changed 0.0% year-over-year to $78000.0 in Q4 2016; TTM through Dec 2016 was $78000.0, a 0.0% change from a year earlier, with the FY2016 full-year figure at $78000.0, changed 0.0% from the prior year.
- Goodwill & Intangibles grew to $78000.0 in Q4 2016 per GALT's latest filing, from $3000.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $78000.0 in Q4 2013 and bottomed at $3000.0 in Q3 2016.
- The 5-year median for Goodwill & Intangibles is $22500.0 (2013), against an average of $28350.0.
- Across the five-year window, Goodwill & Intangibles tumbled 80.77% in 2014 and surged 420.0% in 2015, its largest moves.
- Year by year, Goodwill & Intangibles stood at $30000.0 in 2012, then surged by 160.0% to $78000.0 in 2013, then tumbled by 80.77% to $15000.0 in 2014, then jumped by 420.0% to $78000.0 in 2015, then changed by 0.0% to $78000.0 in 2016.
- Per Business Quant, the three latest GALT Goodwill & Intangibles figures stand at $78000.0 (Q4 2016), $3000.0 (Q3 2016), and $5000.0 (Q2 2016).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 220.37 Mn | 220.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 78,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Dec 31, 2015 | 78,000.00 |
| Sep 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 12,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Dec 31, 2014 | 15,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 78,000.00 |
| Sep 30, 2013 | 24,000.00 |
| Jun 30, 2013 | 26,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 30,000.00 |
| Sep 30, 2012 | 33,000.00 |
| Jun 30, 2012 | 34,000.00 |
| Mar 31, 2012 | 35,000.00 |